Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)
Open Access
- 15 June 2023
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 35, 101706
Abstract
No abstract availableKeywords
Funding Information
- State of Baden-Wurttemberg Ministry for Science Research and Art
This publication has 33 references indexed in Scilit:
- Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesBreast Cancer Research, 2014
- Sequenza: allele-specific copy number and mutation profiles from tumor sequencing dataAnnals of Oncology, 2014
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approachesTrends in Genetics, 2014
- Copynumber: Efficient algorithms for single- and multi-track copy number segmentationBMC Genomics, 2012
- Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 InactivationCancer Research, 2012
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancerBritish Journal of Cancer, 2012
- Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging AgentsCancer Discovery, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences, 2010